Delta-Fly Pharma Stock

Delta-Fly Pharma EBITDA per Employee

The EBITDA per Employee of Delta-Fly Pharma (4598.T) as of Aug 19, 2026 is -87.41 M JPY. In the previous year, EBITDA per Employee was -77.48 M JPY — a change of 12.82% (lower).

EBITDA per Employee

-87.41 MJPY

YoY

12.82%

Last updated:

EBITDA per Employee of Delta-Fly Pharma is 2026 -87.41 M JPY. EBITDA per Employee of Delta-Fly Pharma was 2025 -77.48 M JPY. It decreases by 12.82% lower compared to the previous year.
Access this data via the Eulerpool API

Delta-Fly Pharma Stock analysis

What does Delta-Fly Pharma do? Delta-Fly Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Delta-Fly Pharma stock

EBITDA per Employee of Delta-Fly Pharma is -87.41 M JPY in 2026.

EBITDA per Employee of Delta-Fly Pharma changed from -77.48 M JPY to -87.41 M JPY, representing a 12.82% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Delta-Fly Pharma since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Delta-Fly Pharma historically and in real time.

Access this data via the Eulerpool API

Workforce — Delta-Fly Pharma

All Key Metrics — Delta-Fly Pharma